PMID- 22121257
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20120823
LR  - 20211021
IS  - 1998-3611 (Electronic)
IS  - 0019-5154 (Print)
IS  - 0019-5154 (Linking)
VI  - 56
IP  - 5
DP  - 2011 Sep-Oct
TI  - The immune reconstitution inflammatory syndrome.
PG  - 476-9
LID - 10.4103/0019-5154.87114 [doi]
AB  - A paradoxical clinical worsening of a known condition or the appearance of a new 
      condition after initiating antiretroviral therapy in HIV-infected patients is 
      defined as immune reconstitution inflammatory syndrome (IRIS). Because of wide 
      variation in clinical presentation and the still increasing spectrum of symptoms 
      and etiologies reported, diagnosis remains problematic. Furthermore, no test is 
      currently available to establish an IRIS diagnosis. Until a greater understanding 
      of the syndrome is achieved in different regions of the world, clinicians need to 
      remain vigilant when initiating ART and individualize therapy according to known 
      treatment options for the specific infectious agent.
FAU - Bosamiya, Sanjay S
AU  - Bosamiya SS
AD  - Department of Dermatology, Surat Municipal Institute of Medical Education and 
      Research, Umarwada, Surat, Gujarat, India.
LA  - eng
PT  - Journal Article
PL  - India
TA  - Indian J Dermatol
JT  - Indian journal of dermatology
JID - 0370750
PMC - PMC3221202
OTO - NOTNLM
OT  - Adapalene
OT  - occlusion
OT  - plantar warts
OT  - treatment
COIS- Conflict of Interest: Nil.
EDAT- 2011/11/29 06:00
MHDA- 2011/11/29 06:01
PMCR- 2011/09/01
CRDT- 2011/11/29 06:00
PHST- 2011/11/29 06:00 [entrez]
PHST- 2011/11/29 06:00 [pubmed]
PHST- 2011/11/29 06:01 [medline]
PHST- 2011/09/01 00:00 [pmc-release]
AID - IJD-56-476 [pii]
AID - 10.4103/0019-5154.87114 [doi]
PST - ppublish
SO  - Indian J Dermatol. 2011 Sep-Oct;56(5):476-9. doi: 10.4103/0019-5154.87114.